BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35311112)

  • 1. A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy.
    Ye M; Tong L; Zheng X; Wang H; Zhou H; Zhu X; Zhou C; Zhao P; Wang Y; Wang Q; Bai L; Cai Z; Kong FS; Wang Y; Li Y; Feng M; Ye X; Yang D; Liu Z; Zhang Q; Wang Z; Han S; Sun L; Zhao N; Yu Z; Zhang J; Zhang X; Katz RL; Sun J; Bai C
    Front Oncol; 2022; 12():853801. PubMed ID: 35311112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the diagnostic accuracy of a ctDNA methylation classifier for incidental lung nodules: protocol for a prospective, observational, and multicenter clinical trial of 10,560 cases.
    Liang W; Liu D; Li M; Wang W; Qin Z; Zhang J; Zhang Y; Hu Y; Bao H; Xiang Y; Wang B; Wu J; Sun J; Hu C; Ye X; Zhang X; Xiao W; Yun C; Sun D; Wang W; Chang N; Zhang Y; Zhao J; Zhang X; Xu J; Wu D; Liu X; Guo Y; Zhang Q; Zhang W; Yang L; Li Z; Zhang X; Han B; Tong Z; He J; Qu J; Fan JB; Zhong N
    Transl Lung Cancer Res; 2020 Oct; 9(5):2016-2026. PubMed ID: 33209621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules.
    Tahvilian S; Kuban JD; Yankelevitz DF; Leventon D; Henschke CI; Zhu J; Baden L; Yip R; Hirsch FR; Reed R; Brown A; Muldoon A; Trejo M; Katchman BA; Donovan MJ; Pagano PC
    BMC Pulm Med; 2023 Jun; 23(1):193. PubMed ID: 37277788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules.
    Lin Y; Leng Q; Jiang Z; Guarnera MA; Zhou Y; Chen X; Wang H; Zhou W; Cai L; Fang H; Li J; Jin H; Wang L; Yi S; Lu W; Evers D; Fowle CB; Su Y; Jiang F
    Int J Cancer; 2017 Sep; 141(6):1240-1248. PubMed ID: 28580707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lung Cancer Prediction Model "Stress Test": Assessment of Models' Performance in a High-Risk Prospective Pulmonary Nodule Cohort.
    Heideman BE; Kammer MN; Paez R; Swanson T; Godfrey CM; Low SW; Xiao D; Li TZ; Richardson JR; Knight MA; Shojaee S; Deppen SA; Lentz RJ; Grogan EL; Maldonado F
    CHEST Pulm; 2024 Mar; 2(1):. PubMed ID: 38737731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-aided diagnostic scheme for distinction between benign and malignant nodules in thoracic low-dose CT by use of massive training artificial neural network.
    Suzuki K; Li F; Sone S; Doi K
    IEEE Trans Med Imaging; 2005 Sep; 24(9):1138-50. PubMed ID: 16156352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy.
    Reid M; Choi HK; Han X; Wang X; Mukhopadhyay S; Kou L; Ahmad U; Wang X; Mazzone PJ
    Chest; 2019 Aug; 156(2):367-375. PubMed ID: 30940455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT.
    Uthoff J; Stephens MJ; Newell JD; Hoffman EA; Larson J; Koehn N; De Stefano FA; Lusk CM; Wenzlaff AS; Watza D; Neslund-Dudas C; Carr LL; Lynch DA; Schwartz AG; Sieren JC
    Med Phys; 2019 Jul; 46(7):3207-3216. PubMed ID: 31087332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prediction Model Based on Biomarkers and Clinical Characteristics for Detection of Lung Cancer in Pulmonary Nodules.
    Ma J; Guarnera MA; Zhou W; Fang H; Jiang F
    Transl Oncol; 2017 Feb; 10(1):40-45. PubMed ID: 27889655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of radiomics-based predictive models in low-dose CT screening for early lung cancer diagnosis.
    Garau N; Paganelli C; Summers P; Choi W; Alam S; Lu W; Fanciullo C; Bellomi M; Baroni G; Rampinelli C
    Med Phys; 2020 Sep; 47(9):4125-4136. PubMed ID: 32488865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
    Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
    Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
    Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions.
    Rzyman W; Jelitto-Gorska M; Dziedzic R; Biadacz I; Ksiazek J; Chwirot P; Marjanski T
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):969-73. PubMed ID: 24008181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed Tomography Features of Lung Structure Have Utility for Differentiating Malignant and Benign Pulmonary Nodules.
    Uthoff JM; Mott SL; Larson J; Neslund-Dudas CM; Schwartz AG; Sieren JC;
    Chronic Obstr Pulm Dis; 2022 Apr; 9(2):154-164. PubMed ID: 35021316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
    Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
    Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm.
    Ye M; Zheng X; Ye X; Zhang J; Huang C; Liu Z; Huang M; Fan X; Chen Y; Xiao B; Sun J; Bai C
    Front Oncol; 2021; 11():638223. PubMed ID: 33777797
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.